Seeing Is Believing
SLN is currently covered by 4 analysts with an average price target of $45.78. This is a potential upside of $24.17 (111.85%) from yesterday's end of day stock price of $21.61.
Silence Therapeutics PLC's activity chart (see below) currently has 2 price targets and 21 ratings on display. The stock rating distribution of SLN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 46.43% with an average time for these price targets to be met of 131.75 days.
Highest price target for SLN is $75, Lowest price target is $15, average price target is $45.78.
Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 22-Apr-2024. First documented stock forecast 18-Nov-2020.
Currently out of the existing stock ratings of SLN, 19 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
45
$22.73 (102.07%)
20
6 days ago
6/7 (85.71%)
$22.5 (100.00%)
223
Buy
75
$52.73 (236.78%)
75
1 months 15 days ago
0/4 (0%)
$49.39 (192.85%)
Buy
15
$-7.27 (-32.64%)
32
5 months 13 days ago
1/2 (50%)
$5.58 (59.24%)
27
Buy
26
$3.73 (16.75%)
26
8 months 11 days ago
2/4 (50%)
$19.19 (281.79%)
277
What is SLN (Silence Therapeutics PLC) average time for price targets to be met?
Which analyst has the current highest performing score on SLN (Silence Therapeutics PLC) with a proven track record?
Which analyst has the current lower performing score on SLN (Silence Therapeutics PLC) with a proven track record?
Which analyst has the most public recommendations on SLN (Silence Therapeutics PLC)?
Which analyst is the currently most bullish on SLN (Silence Therapeutics PLC)?
Which analyst is the currently most reserved on SLN (Silence Therapeutics PLC)?